-
October 22, 2020 Psychedelic Tech Company Cybin Brings In a $45 Million (CAD) Funding RoundCanadian pharmaceutical therapies company Cybin announced $45 million (CAD) in gross proceeds on a private...
-
October 8, 2020 Dr. Andrew Weil Joins Advisory Board for Psychedelic Therapy Platform Field TripAcclaimed integrative medicine pioneer, Dr. Andrew Weil, has joined the advisory board for psychedelic therapy...
-
October 7, 2020 Field Trip Is the Latest Psychedelic Therapy Company to Go PublicAnother psychedelic therapy-based company has gone public. Toronto-based Field Trip Health Ltd., which operates the...
-
September 30, 2020 Ibogaine and LSD Producer MindMed Applies for Nasdaq Up-ListingJust days after UK-based psychedelic developer Compass Pathways went public, New York-based MindMed has applied for a...
-
September 24, 2020 Compass Pathways IPO Brings $1 Billion ValuationUK-based Compass Pathways led a groundbreaking IPO last week. Share prices spiked 71 percent to...
-
September 23, 2020 Why Investors Are Betting On PsychedelicsWhile they’ve historically brought the risk of long jail sentences, psychedelics are now bringing another...
-
September 22, 2020 The Psychedelic Medicine Association Launches to Align the IndustryA first of its kind, The Psychedelic Medicine Association (PMA) is set to launch on...
-
September 17, 2020 New Partnership Will Bring Quick-Dissolve Strips to PsychedelicsPsychedelic drugs could soon have a standardized, and much faster delivery method with the announcement last month...
-
September 14, 2020 CEO of Canadian Stock Exchange on Psychedelic InvestmentsListening to Richard Carleton – the CEO of the Canadian Securities Exchange – talk about...
-
September 10, 2020 Canadian Manufacturer Licensed to Make PsilocybinVancouver-based Mydecine Innovations Group, Inc., has become the first company to earn the license to...
